chr5-151676076-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_003118.4(SPARC):c.57+56G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0932 in 1,450,910 control chromosomes in the GnomAD database, including 10,201 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.16 ( 3511 hom., cov: 32)
Exomes 𝑓: 0.085 ( 6690 hom. )
Consequence
SPARC
NM_003118.4 intron
NM_003118.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0470
Publications
6 publications found
Genes affected
SPARC (HGNC:11219): (secreted protein acidic and cysteine rich) This gene encodes a cysteine-rich acidic matrix-associated protein. The encoded protein is required for the collagen in bone to become calcified but is also involved in extracellular matrix synthesis and promotion of changes to cell shape. The gene product has been associated with tumor suppression but has also been correlated with metastasis based on changes to cell shape which can promote tumor cell invasion. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2015]
SPARC Gene-Disease associations (from GenCC):
- osteogenesis imperfecta type 17Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: G2P, Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics
- osteogenesis imperfecta type 4Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 5-151676076-C-G is Benign according to our data. Variant chr5-151676076-C-G is described in ClinVar as [Benign]. Clinvar id is 1281906.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.381 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPARC | NM_003118.4 | c.57+56G>C | intron_variant | Intron 2 of 9 | ENST00000231061.9 | NP_003109.1 | ||
SPARC | NM_001309444.2 | c.57+56G>C | intron_variant | Intron 2 of 9 | NP_001296373.1 | |||
SPARC | NM_001309443.2 | c.57+56G>C | intron_variant | Intron 2 of 9 | NP_001296372.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.163 AC: 24755AN: 151904Hom.: 3494 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
24755
AN:
151904
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0850 AC: 110359AN: 1298890Hom.: 6690 AF XY: 0.0860 AC XY: 55924AN XY: 650082 show subpopulations
GnomAD4 exome
AF:
AC:
110359
AN:
1298890
Hom.:
AF XY:
AC XY:
55924
AN XY:
650082
show subpopulations
African (AFR)
AF:
AC:
12141
AN:
30304
American (AMR)
AF:
AC:
2235
AN:
38738
Ashkenazi Jewish (ASJ)
AF:
AC:
1916
AN:
24546
East Asian (EAS)
AF:
AC:
2846
AN:
37926
South Asian (SAS)
AF:
AC:
10819
AN:
78960
European-Finnish (FIN)
AF:
AC:
4067
AN:
51144
Middle Eastern (MID)
AF:
AC:
563
AN:
5456
European-Non Finnish (NFE)
AF:
AC:
70480
AN:
977058
Other (OTH)
AF:
AC:
5292
AN:
54758
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
4509
9018
13528
18037
22546
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2742
5484
8226
10968
13710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.163 AC: 24810AN: 152020Hom.: 3511 Cov.: 32 AF XY: 0.162 AC XY: 12027AN XY: 74296 show subpopulations
GnomAD4 genome
AF:
AC:
24810
AN:
152020
Hom.:
Cov.:
32
AF XY:
AC XY:
12027
AN XY:
74296
show subpopulations
African (AFR)
AF:
AC:
15983
AN:
41430
American (AMR)
AF:
AC:
1366
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
311
AN:
3464
East Asian (EAS)
AF:
AC:
333
AN:
5160
South Asian (SAS)
AF:
AC:
671
AN:
4826
European-Finnish (FIN)
AF:
AC:
935
AN:
10554
Middle Eastern (MID)
AF:
AC:
29
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4848
AN:
67992
Other (OTH)
AF:
AC:
306
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
917
1835
2752
3670
4587
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
248
496
744
992
1240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
392
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Aug 20, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.